Abstract
Seventy-two hypertensive patients were treated with pindolol, a beta adrenergic blocking drug with intrinsic sympathomimetic activity. Serial measurements of systolic time intervals were utilized (1) to determine whether the therapeutic response to pindolol was predictable from pretreatment measurements, and (2) to assess changes in cardiac function during a 15 week treatment period. Patients with an abnormal pretreatment ratio of preejection period to left ventricular ejection time (PEP/LVET) of greater than 0.42 were less likely to respond with a decrease in mean blood pressure of greater than 10 percent (8 of 22) than were patients with a normal (0.42 or less) pretreatment PEP/LVET ratio (33 of 50) (p
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.